Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.0 - $1.39 $1,700 - $2,363
1,700 New
1,700 $1,000
Q2 2023

Aug 11, 2023

SELL
$2.95 - $4.44 $13,693 - $20,610
-4,642 Reduced 80.26%
1,142 $4,000
Q1 2023

May 12, 2023

BUY
$2.94 - $4.18 $14,652 - $20,833
4,984 Added 623.0%
5,784 $19,000
Q4 2022

Feb 08, 2023

SELL
$2.73 - $3.7 $9,606 - $13,020
-3,519 Reduced 81.48%
800 $2,000
Q3 2022

Nov 10, 2022

BUY
$0.48 - $3.48 $1,402 - $10,168
2,922 Added 209.16%
4,319 $11,000
Q2 2022

Aug 10, 2022

SELL
$2.22 - $4.54 $894 - $1,829
-403 Reduced 22.39%
1,397 $3,000
Q1 2022

May 16, 2022

SELL
$3.58 - $4.98 $15,648 - $21,767
-4,371 Reduced 70.83%
1,800 $8,000
Q4 2021

Feb 14, 2022

BUY
$4.17 - $7.09 $17,138 - $29,139
4,110 Added 199.42%
6,171 $30,000
Q3 2021

Nov 15, 2021

BUY
$5.87 - $7.85 $1,303 - $1,742
222 Added 12.07%
2,061 $13,000
Q2 2021

Aug 13, 2021

SELL
$6.69 - $9.0 $37,223 - $50,076
-5,564 Reduced 75.16%
1,839 $13,000
Q1 2021

May 12, 2021

SELL
$8.26 - $11.4 $55,622 - $76,767
-6,734 Reduced 47.63%
7,403 $61,000
Q4 2020

Feb 11, 2021

SELL
$8.21 - $18.59 $5,878 - $13,310
-716 Reduced 4.82%
14,137 $120,000
Q3 2020

Nov 12, 2020

BUY
$11.33 - $19.81 $128,312 - $224,348
11,325 Added 321.0%
14,853 $276,000
Q2 2020

Jul 31, 2020

BUY
$4.2 - $15.45 $14,817 - $54,507
3,528 New
3,528 $40,000
Q1 2020

May 01, 2020

SELL
$3.38 - $10.63 $7,544 - $23,726
-2,232 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$5.74 - $7.42 $2,318 - $2,997
-404 Reduced 15.33%
2,232 $16,000
Q3 2019

Nov 14, 2019

BUY
$4.68 - $7.42 $12,336 - $19,559
2,636 New
2,636 $18,000
Q1 2019

May 14, 2019

SELL
$4.19 - $5.25 $3,456 - $4,331
-825 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$3.51 - $8.6 $2,895 - $7,095
825 New
825 $3,000
Q2 2018

Aug 14, 2018

SELL
$5.27 - $6.21 $13,928 - $16,413
-2,643 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.91 - $7.72 $12,977 - $20,403
2,643 New
2,643 $15,000
Q2 2017

Aug 14, 2017

SELL
N/A
-500 Closed
0 $0
Q1 2017

Nov 14, 2017

BUY
N/A
500
500 $4,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.